Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23658677)

  • 1. Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.
    Chen SF; Lin YS; Jao SW; Chang YC; Liu CL; Lin YJ; Nieh S
    PLoS One; 2013; 8(5):e54659. PubMed ID: 23658677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.
    Ricci A; De Vitis C; Noto A; Fattore L; Mariotta S; Cherubini E; Roscilli G; Liguori G; Scognamiglio G; Rocco G; Botti G; Giarnieri E; Giovagnoli MR; De Toma G; Ciliberto G; Mancini R
    Cell Cycle; 2013 Jun; 12(11):1696-703. PubMed ID: 23656788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMT markers in lung adenocarcinoma pleural effusion spheroid cells.
    Giarnieri E; De Vitis C; Noto A; Roscilli G; Salerno G; Mariotta S; Ricci A; Bruno P; Russo G; Laurenzi A; Giovagnoli MR; Ciliberto G; Mancini R
    J Cell Physiol; 2013 Aug; 228(8):1720-6. PubMed ID: 23255165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.
    Basak SK; Veena MS; Oh S; Huang G; Srivatsan E; Huang M; Sharma S; Batra RK
    PLoS One; 2009 Jun; 4(6):e5884. PubMed ID: 19536353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of cancer stem cell-related marker expression is associated with three-dimensional structures in malignant pleural effusion produced by lung adenocarcinoma.
    Lin YY; Lin YS; Liang CW
    Cytopathology; 2024 Jan; 35(1):105-112. PubMed ID: 37897199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
    Bruschini S; di Martino S; Pisanu ME; Fattore L; De Vitis C; Laquintana V; Buglioni S; Tabbì E; Cerri A; Visca P; Alessandrini G; Facciolo F; Napoli C; Trombetta M; Santoro A; Crescenzi A; Ciliberto G; Mancini R
    J Cell Physiol; 2020 Mar; 235(3):1877-1887. PubMed ID: 31397494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
    Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
    BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma.
    Laberiano-Fernandez C; Gan Q; Wang SM; Tamegnon A; Wistuba I; Yoon E; Roy-Chowdhuri S; Parra ER
    J Am Soc Cytopathol; 2024; 13(3):161-173. PubMed ID: 38519275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
    Phiboonchaiyanan PP; Chanvorachote P
    Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
    Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
    Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
    Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
    PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.